Your browser doesn't support javascript.
loading
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.
Best, Scott; Lam, Vi; Liu, Tingting; Bruss, Nur; Kittai, Adam; Danilova, Olga V; Murray, Susan; Berger, Allison; Pennock, Nathan D; Lind, Evan F; Danilov, Alexey V.
Affiliation
  • Best S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Lam V; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Liu T; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Bruss N; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Kittai A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Danilova OV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Murray S; University of Portland, Portland, OR, USA.
  • Berger A; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.
  • Pennock ND; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA.
  • Lind EF; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Danilov AV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. adanilov@coh.org.
Leukemia ; 35(1): 156-168, 2021 01.
Article de En | MEDLINE | ID: mdl-32203139

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrimidines / Leucémie prolymphocytaire à cellules T / Cyclopentanes / Immunomodulation / Protéine NEDD8 / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrimidines / Leucémie prolymphocytaire à cellules T / Cyclopentanes / Immunomodulation / Protéine NEDD8 / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni